PNNL welcomes four new Lab Fellows
At the Pacific Northwest National Laboratory, one of the highest levels of scientific and technical achievement and recognition is being named Laboratory Fellow. These individuals consistently demonstrate creativity and leadership in their respective fields of research. PNNL is pleased to announce that Yong Wang, Fabrizio Petrini, Thomas Squier and TP Straatsma were bestowed the honor of Laboratory Fellow.
Yong Wang focuses on the areas of catalysis and reaction engineering. He is noted for his discoveries in microchannel reaction technology, specifically, highly active catalysts for microchannel reactor applications. His success in linking catalysis science and reaction engineering are breaking new ground in the way conventional chemical processes are operated and enabling process intensification in important energy areas.
Fabrizio Petrini is an internationally recognized expert in high-performance networks, job scheduling algorithms, scalable system software design for large-scale parallel computers, and predictive performance modeling of scientific parallel applications. He is currently working on Buffered Coscheduling to design scalable operating systems for supercomputers.
Tom Squier has an established background in the field of calcium homeostasis and transport in biological systems. He has expanded this research emphasis to participate in the growth of multidisciplinary biological research at the Laboratory, making major contributions to staff, program, and business development.
TP Straatsma has more than 25 years experience in the development, efficient implementation, and application of advanced modeling and simulation methods as key scientific tools in the computational study of chemical and biological systems. He is an internationally recognized scientist with an extensive background in quantum mechanics and classical mechanics approaches.
PNNL wins four technology transfer awards
Pacific Northwest National Laboratory has received four 2006 Excellence in Technology Transfer Awards from the Federal Laboratory Consortium—the maximum number of awards allowed in a given year. PNNL was recognized for transferring technologies that treat and cure cancer, uniquely analyze massive sets of data, increase surgical implant success rates, and neutralize toxic chemicals from the environment.
Through collaboration with PNNL researchers and access to facilities at PNNL, IsoRay Medical, Inc., expanded its brachytherapy technology for treating prostate and other cancers. The medical isotope "seed" products are available at more than 17 implant centers nationwide. More than 40 organizations, including Fortune 500 companies, are using the Starlight information visualization software to mine and interpret massive amounts of data. Bacterin International licensed bioactive thin-film coatings, which reduce infection rates associated with surgical implants. Self-Assembled Monolayers on Mesoporous Silica (SAMMS), a process for removing mercury and other toxic chemicals from the environment, was licensed to Steward Advanced Materials for use in coal-fired power plants, municipal incinerators, and other plants.
The Federal Laboratory Consortium is a nationwide network of more than 700 major federal laboratories and centers as well as their parent departments and agencies that provides a forum to develop strategies and opportunities for linking technology with the research mission and the marketplace.
The FLC presents its Awards for Excellence in Technology Transfer to federal laboratory employees who have done outstanding work in transferring U.S. government-sponsored technologies to the public and private sectors. Since 1984, when the awards program was established, PNNL has earned 62 of these awards, more than any other national laboratory.